PAYDEN SHAPLAND: Open Payments
NPI 1659071181 · LAKIN, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$303 in 14 payments from 10 companies in 2025. Trend: 2023 $57 · 2024 $183 · 2025 $303
Food & beverage: $303
| Company | Payments | Amount |
|---|---|---|
| Aimmune Therapeutics, Inc. | 2 | $52 |
| Corcept Therapeutics | 3 | $52 |
| Xeris Pharmaceuticals, Inc. | 2 | $50 |
| Medtronic, Inc. | 1 | $28 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $28 |
| BETA BIONICS, INC. | 1 | $25 |
| Astellas Pharma US Inc | 1 | $20 |
| Insulet Corporation | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
| ABBVIE INC. | 1 | $14 |
Products named: ZENPEP, Korlym, RECORLEV, MINIMED 780G, ISTURISA, iLet Bionic Pancreas, Veozah, Omnipod.
Industry payments across KS — which companies pay providers there.
